Insight Holdings Group, Llc Sells 530,982 Shares of Hinge Health (NYSE:HNGE) Stock

Hinge Health Inc. (NYSE:HNGE) major shareholder Insight Holdings Group, Llc sold 530,982 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $71.82, for a total value of $38,135,127.24. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Insight Holdings Group, Llc also recently made the following trade(s):

• On Monday, June 29th, Insight Holdings Group, Llc sold 1,466,667 shares of Hinge Health stock. The shares were sold at an average price of $82.83, for a total value of $121,484,027.61.
• On Wednesday, June 24th, Insight Holdings Group, Llc sold 142,311 shares of Hinge Health stock. The stock was sold at an average price of $71.67, for a total value of $10,199,429.37.
• On Wednesday, June 24th, Insight Holdings Group, Llc sold 390,917 shares of Hinge Health stock. The stock was sold at an average price of $71.15, for a total transaction of $27,813,744.55.
• On Tuesday, June 23rd, Insight Holdings Group, Llc sold 112,477 shares of Hinge Health stock. The shares were sold at an average price of $70.21, for a total transaction of $7,897,010.17.
• On Monday, June 22nd, Insight Holdings Group, Llc sold 224,399 shares of Hinge Health stock. The stock was sold at an average price of $70.95, for a total transaction of $15,921,109.05.
• On Tuesday, June 16th, Insight Holdings Group, Llc sold 65,581 shares of Hinge Health stock. The stock was sold at an average price of $70.36, for a total transaction of $4,614,279.16.

Hinge Health Trading Up 2.6%

HNGE opened at $85.14 on Thursday. The company has a fifty day moving average price of $59.32 and a two-hundred day moving average price of $48.25. Hinge Health Inc. has a 1-year low of $30.08 and a 1-year high of $86.66. The company has a market cap of $6.59 billion, a P/E ratio of -6.90 and a beta of 1.10.

Hinge Health (NYSE:HNGE) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.33. The company had revenue of $182.31 million for the quarter. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. Hinge Health’s revenue for the quarter was up 47.2% compared to the same quarter last year. During the same period last year, the company earned $1.30 EPS. On average, research analysts forecast that Hinge Health Inc. will post 1.33 EPS for the current fiscal year.

Analyst Ratings Changes

HNGE has been the subject of a number of research reports. Needham & Company LLC raised their price objective on Hinge Health from $63.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday, June 11th. Canaccord Genuity Group increased their target price on Hinge Health from $65.00 to $76.00 and gave the stock a “buy” rating in a report on Monday, June 15th. Wall Street Zen downgraded shares of Hinge Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 6th. KeyCorp boosted their price target on shares of Hinge Health from $75.00 to $90.00 and gave the company an “overweight” rating in a research note on Friday, June 12th. Finally, Zacks Research upgraded shares of Hinge Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $75.80.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of HNGE. Wells Fargo & Company MN boosted its position in shares of Hinge Health by 160.0% during the fourth quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock valued at $25,000 after buying an additional 336 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in Hinge Health in the 4th quarter valued at $26,000. First Horizon Corp lifted its stake in Hinge Health by 163.9% during the 4th quarter. First Horizon Corp now owns 855 shares of the company’s stock valued at $40,000 after acquiring an additional 531 shares in the last quarter. CENTRAL TRUST Co bought a new position in Hinge Health during the 1st quarter valued at $37,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in Hinge Health during the 3rd quarter worth $49,000.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.